<DOC>
	<DOCNO>NCT00648310</DOCNO>
	<brief_summary>Despite great number report efficacy oestrogens antimuscarinics OAB symptom , far author tried investigate whether concomitant administration two drug , act two different pathophysiological mechanism , could synergic effect reduce rate non-responders treatment .</brief_summary>
	<brief_title>Topical Oestrogens Antimuscarinics In The Treatment Of Detrusor Overactivity</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>All postmenopausal woman symptom overactive bladder urodynamically proven pure detrusor overactivity concomitant urodynamic stress incontinence document recurrent urinary tract infection previous antimuscarinic treatment previous pelvic surgery concomitant systemic HRT history breast endometrial cancer neurological disease clinical contraindication treatment oestrogen antimuscarinics patient include ongoing clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>